Close Menu

expansion

The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.

The new division will enable BGI to expand partnerships with universities, companies, and health and agriculture-related organizations, among other things.

Pacific Biosciences announced this week that it has reached the final developmental milestone of its commercialization and licensing agreement with Roche.

The company will focus on gaining customers for its custom and pre-defined hybrid capture kits first in Southern California, and then across the US.

The company will use some of the funds to set up a new research laboratory within the US to better support collaborations with pharma and biotech.

The company has opened a new office and is hiring to fill multiple positions in software development, support, and more.

NEW YORK (GenomeWeb) – Illumina will build a new 150,000-square-foot facility in San Diego to house manufacturing and logistics, the company and the city said on Tuesday.

NEW YORK (GenomeWeb News) – Personalis has formed a UK subsidiary, Personalis UK Limited, to serve its customers in Europe.
Menlo Park, Calif.-based Personalis provides researchers and clinicians human DNA sequencing and interpretation services.

NEW YORK (GenomeWeb News) – Boston University has proposed building a new research center that will house interdisciplinary life sciences research projects involving systems and synthetic biology and neuroscience.

NEW YORK (GenomeWeb News) – Life Technologies today announced it will invest $18 million to expand its facility in Pleasanton, Calif., where the company will implement current good manufacturing practice capabilities for its genetic analysis products.

Pages

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.